• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

1st British Symposium on Diabetic Neuropathy

November 25th 2016
King’s College London
Denmark Hill Campus
London, United Kingdom

Keynote introduction
Looking back to the future. What the past tells us on Diabetic Neuropathy.
Dr Peter Watkins, Retired Diabetologist, King’s College Hospital, London, UK

Diabetic Somatic Neuropathy
Diabetic Somatic Neuropathy – epidemiology, risk factors and challenges.
Professor Rayaz Malik, Professor of Medicine & Consultant Physician, Manchester Royal Infirmary & University of Manchester, UK

Small Fibre Neuropathy assessment- When is it helpful – structure, function or both?
Dr Gerry Rayman, National Diabetes Director, lpswich Hospital, UK

Diabetic Sensorimotor Neuropathy – a neurology perspective.
Dr Rob Hadden, Neurologist, King’s College Hospital, London, UK

Prediabetic Neuropathy.
Dr Nikolaos Papanas, Associate Professor in Internal Medicine, Democritus University of Thrace, Greece

Diabetic Autonomic Neuropathy
Diabetic Autonomic Neuropathy – why is it important?
Professor Simona Fontani, Chairperson of NEURODiab, University of Rome Tor Vergata, Italy

The Autonomic Lab.
Dr Shane Delamont, Neurologist, King’s College Hospital, London, UK

Visceral Autonomic Neuropathy.
Dr Eirik Softeland, Leading Consultant Head and Neck Section, Haukeland University Hospital, Bergen, Norway

Gastroparesis – management with focus on interventional techniques.
Dr David Hopkins, Liaison Diabetologist for Renal Medicine King’s College Hospital, London, UK

Diabetic Painful Neuropathy
Can we objectively quantify pain?
Dr Jordi Serra, Consultant Neurologist and Clinical Neurophysiologist, Kings College Hospital, London and the University of Barcelona, Spain

Management of neuropathic pain.
Professor Solomon Tesfaye, Consultant Physician/Endocrinologist, Sheffield Teaching Hospitals, Sheffield, UK

Psychological impact.
Professor Khalida Ismail, Professor of Diabetes Psychiatric, King’s College, London, UK

Established Diabetic Neuropathy – consequences.
Professor Michael Edmonds, Professor of Diabetes and Endocrinology, King’s College Hospital, London, UK

Chairpersons:
Dr Prashanth VasConsultant Diabetologist
& Diabetic Foot Physician,
King’s College Hospital,
London, UK

Dinesh Selvarajah

 

Honorary Consultant Diabetologist
Sheffield Teaching Hospitals
NHS Foundation Trust
Sheffield, UK

Supported and Endorsed by:

Supported by educational grants from the Pharmaceutical Industry.
A list of 2016 supporters is at http://www.atthelimits.org/supporters-2016

Leave a comment Cancel reply

You must be logged in to post a comment.

Cardiology, Diabetes & Nephrology at the Limits Canada
Wednesday, 3 & Thursday, 4 March 2021, Virtual Meeting

Cardiology, Diabetes & Nephrology at the Limits 2021
Monday, 12 & Tuesday, 13 April 2021, Virtual Meeting

The 18th Malvern Diabetic Foot Conference
Wednesday, 12 – Friday, 14 May 2021, Malvern, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 10 & Saturday, 11 September 2021, London, UK

Multiple Sclerosis at the Limits
Monday, 13 & Tuesday, 14 September 2021, London, UK

Hatter Horizon GP Meeting
Monday, 1 November 2021
London, UK

Cell Therapy at the Limits 2021
Monday, 8 & Tuesday, 9 November 2021, London, UK

Hatter Horizon Series
Monday, 22 November 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 10 - Saturday, 11 December 2021, São Paulo, Brazil

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2021 At the Limits Ltd.
This site uses cookies More info